Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study

doi:10.12998/wjcc.v9.i15.3546

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5443)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

215

WORD

150

HTML

2177

Figures (1-1)

526

Tables (1-4)

229

Sum=3297

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

461

Download

498

Sum=959

Publishing Process of This Article

Item

Count

Browse

366

Download

821

Sum=1187

May 26, 2021 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. May 26, 2021; 9(15): 3546-3558
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3546

Table 4 Results of imaging evaluation in patients with coronavirus disease-19

Variables	Corticosteroid group		Non-corticosteroid group
Variables	D 0	D 14	D 0	D 14
Total lesion volume ratio (%)	22.14 ± 12.62^a	11.21 ± 8.17^b	12.80 ± 8.32	12.05 ± 9.44
Consolidation volume ratio (%)	4.59 ± 4.46^a	2.77 ± 3.99^b	1.68 ± 1.47	2.81 ± 2.87^b
GGO volume ratio (%)	17.26 ± 12.35^a	8.31 ± 5.73^b	11.30 ± 7.85	9.15 ± 7.63

^aP < 0.05 vs non-corticosteroid group.

^bP < 0.05 vs baseline (D 0) in each group. GGO: Ground-glass opacity.

Citation: Xiong B, He LM, Qin YY, Du H, Zhan Z, Zhou YH, Chen YK, Zhang A. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: A retrospective cohort study. World J Clin Cases 2021; 9(15): 3546-3558
URL: https://www.wjgnet.com/2307-8960/full/v9/i15/3546.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i15.3546